COX-2 Inhibitor Screening Kit
To Order Contact us: [email protected]
?-Amylase Inhibitor Screening Kit |
|
K482-100 |
Biovision |
each |
EUR 574.8 |
Lysozyme Inhibitor Screening Kit |
|
K237-100 |
Biovision |
each |
EUR 777.6 |
MMP-3 Inhibitor Screening Kit |
|
GWB-AXR369 |
GenWay Biotech |
100 assays |
Ask for price |
MMP-1 Inhibitor Screening Kit |
|
GWB-AXR370 |
GenWay Biotech |
100 assays |
Ask for price |
HDAC-3 Inhibitor Screening Kit |
|
GWB-AXR213 |
GenWay Biotech |
100 assays |
Ask for price |
HDAC-8 Inhibitor Screening Kit |
|
GWB-AXR215 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-2 Inhibitor Drug Screening Kit |
|
GWB-AXR116 |
GenWay Biotech |
100 assays |
Ask for price |
SARS-CoV-2 Inhibitor Screening Kit (RBD) |
|
MBS9143985-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3890 |
SARS-CoV-2 Inhibitor Screening Kit (RBD) |
|
MBS9143985-96Tests |
MyBiosource |
96Tests |
EUR 845 |
SARS-CoV-2 Inhibitor Screening Kit(RBD) |
|
RK04194 |
Abclonal |
96T |
EUR 513.66 |
Cathepsin D Inhibitor Screening Kit |
|
GWB-AXR114 |
GenWay Biotech |
100 assays |
Ask for price |
HDAC Inhibitor Drug Screening Kit |
|
GWB-AXR204 |
GenWay Biotech |
100 assays |
Ask for price |
CETP Inhibitor Drug Screening Kit |
|
GWB-AXR273 |
GenWay Biotech |
100 assays |
Ask for price |
PLTP Inhibitor Drug Screening Kit |
|
GWB-AXR276 |
GenWay Biotech |
100 assays |
Ask for price |
KMO Inhibitor Screening Assay Kit |
|
79513-1 |
BPS Bioscience |
96 rxns. |
EUR 790 |
|
Description: The Kynurenine 3-Monooxygenase (KMO) Inhibitor Screening Assay Kit is designed to measure human KMO enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 400 reactions. The KMO Inhibitor Screening Assay Kit is simple to use. Recombinant hKMO is mixed with inhibitors and the reaction is initiated through addition of the substrates NADPH and L-Kynurenine. After a room temperature incubation, activity is determined by measuring the absorption of the reaction product at λ=412 nm. The UV absorption signal correlates with the amount of NADPH remaining in the reaction. |
KMO Inhibitor Screening Assay Kit |
|
79513-2 |
BPS Bioscience |
384 rxns. |
EUR 1070 |
|
Description: The Kynurenine 3-Monooxygenase (KMO) Inhibitor Screening Assay Kit is designed to measure human KMO enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 400 reactions. The KMO Inhibitor Screening Assay Kit is simple to use. Recombinant hKMO is mixed with inhibitors and the reaction is initiated through addition of the substrates NADPH and L-Kynurenine. After a room temperature incubation, activity is determined by measuring the absorption of the reaction product at λ=412 nm. The UV absorption signal correlates with the amount of NADPH remaining in the reaction. |
IDE Inhibitor Screening Assay Kit |
|
78883-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The IDE (Insulin-degrading enzyme) Inhibitor Screening Assay is a homogeneous fluorogenic assay designed to measure the activity of IDE for screening and profiling applications. The IDE assay kit comes in a convenient 96-well or 384-well format and contains enough purified IDE (amino acids 71-254), substrate, and PR-02 buffer for 100 or 400 reactions.Figure 1: Illustration of the assay principle.The substrate is an internally quenched fluorogenic substrate. Proteolysis releases the highly fluorescent Mca from the quencher. Fluorescence intensity increases proportionally to the activity of the protease.Need us to run inhibitor screens or profile your compounds against IDE? Check out ourProtease Screening Services. |
IDE Inhibitor Screening Assay Kit |
|
78883-2 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The IDE (Insulin-degrading enzyme) Inhibitor Screening Assay is a homogeneous fluorogenic assay designed to measure the activity of IDE for screening and profiling applications. The IDE assay kit comes in a convenient 96-well or 384-well format and contains enough purified IDE (amino acids 71-254), substrate, and PR-02 buffer for 100 or 400 reactions.Figure 1: Illustration of the assay principle.The substrate is an internally quenched fluorogenic substrate. Proteolysis releases the highly fluorescent Mca from the quencher. Fluorescence intensity increases proportionally to the activity of the protease.Need us to run inhibitor screens or profile your compounds against IDE? Check out ourProtease Screening Services. |
AHCY Inhibitor Screening Kit (Fluorometric) |
|
K326-100 |
Biovision |
each |
EUR 1201.2 |
ACE1 Inhibitor Screening Kit (Colorimetric) |
|
K719-100 |
Biovision |
each |
EUR 1032 |
DPP4 Inhibitor Screening Kit (Fluorometric) |
|
K780-100 |
Biovision |
each |
EUR 744 |
pCAF Inhibitor Screening Kit (Fluorometric) |
|
K345-100 |
Biovision |
each |
EUR 686.4 |
BRD1 Inhibitor Screening Assay Kit |
|
32521 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD1 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD1 binding to its substrate. The key to the BRD1 Inhibitor Screening Assay Kit is the specific binding of the BRD1 bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
CBX1 Inhibitor Screening Assay Kit |
|
79052 |
BPS Bioscience |
384 rxns. |
EUR 535 |
|
Description: The CBX1 Inhibitor Screening Assay Kit is designed to measure the inhibition of CBX1 binding to its substrate. The kit comes in a convenient AlphaLISA® format, with enough biotinylated peptide substrate, assay buffer, detection buffer and purified GST-tagged CBX1 chromodomain to perform a total of 384 enzyme reactions. The key to the kit is the specific binding of the CBX1 chromodomain to the methylated-peptide substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing CBX1 and an inhibitor of choice is incubated with the biotinylated substrate for one hour. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
USP7 Inhibitor Screening Assay Kit |
|
79256 |
BPS Bioscience |
96 rxns. |
EUR 820 |
|
Description: The USP7 Inhibitor Screening Assay Kit is designed to measure USP7 activity for screening and profiling applications. The USP7 Inhibitor Screening Assay Kit comes in a convenient format, with a 96-well plate, fluorogenic, ubiquitinated substrate, assay buffer, and purified USP7 enzyme for 96 enzyme reactions. USP7 is incubated with a sample containing assay buffer and Ub-AMC Substrate, and then the plate is read, measuring fluorescence using a fluorescence reader. |
CD39 Inhibitor Screening Assay Kit |
|
79278 |
BPS Bioscience |
96 rxns. |
EUR 890 |
|
Description: The CD39 Inhibitor Screening Assay Kit is designed to measure CD39 activity for screening and profiling applications. The CD39 assay kit comes in a convenient 96-well format, with purified recombinant CD39 enzyme, ATP, CD39 assay buffer, and Colorimetric detection reagent for 96 enzyme reactions. In addition, the kit includes the CD39 inhibitor POM-1 for use as an inhibitor control. |
ACE2 Inhibitor Screening Assay Kit |
|
79923 |
BPS Bioscience |
96 rxns. |
EUR 545 |
|
Description: The ACE2 Inhibitor Screening Assay Kit is designed to measure the exopeptidase activity of ACE2 for screening and profiling applications. |
GLS2 Inhibitor Screening Assay Kit |
|
79925 |
BPS Bioscience |
96 rxns. |
EUR 780 |
|
Description: The GLS2 Inhibitor Screening Assay Kit is designed to measure the hydrolase activity of GLS2 for screening and profiling applications. |
UBE1 Inhibitor Screening Assay Kit |
|
79957 |
BPS Bioscience |
96 rxns. |
EUR 765 |
|
Description: UBE1 dysregulation has been linked to muscular atrophy, tumors, and cancer. The UBE1 Inhibitor Screening Assay Kit is designed to measure UBE1 activity for screening and profiling applications using Kinase-Glo® MAX as a detection reagent. |
ARG2 Inhibitor Screening Assay Kit |
|
72043-1 |
BPS Bioscience |
96 rxns. |
EUR 765 |
|
Description: The ARG2 Inhibitor Screening Assay Kit is designed to measure ARG2 enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 100 reactions. The ARG2 Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing thioarginine substrate. After a room temperature incubation, activity is determined by measuring the absorption of reaction product at λ=410-415 nm. |
ARG2 Inhibitor Screening Assay Kit |
|
72043-2 |
BPS Bioscience |
384 rxns. |
EUR 1130 |
|
Description: The ARG2 Inhibitor Screening Assay Kit is designed to measure ARG2 enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 400 reactions. The ARG2 Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing thioarginine substrate. After a room temperature incubation, activity is determined by measuring the absorption of reaction product at λ=410-415 nm. |
ARG1 Inhibitor Screening Assay Kit |
|
72048-1 |
BPS Bioscience |
96 rxns. |
EUR 845 |
|
Description: The ARG1 Inhibitor Screening Assay Kit is designed to measure ARG1 enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 100 reactions. The ARG1 Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing thioarginine substrate. After a room temperature incubation, activity is determined by measuring the absorption of reaction product at λ=410-415 nm. |
ARG1 Inhibitor Screening Assay Kit |
|
72048-2 |
BPS Bioscience |
384 rxns. |
EUR 1245 |
|
Description: The ARG1 Inhibitor Screening Assay Kit is designed to measure ARG1 enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 400 reactions. The ARG1 Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing thioarginine substrate. After a room temperature incubation, activity is determined by measuring the absorption of reaction product at λ=410-415 nm. |
TPH1 Inhibitor Screening Assay Kit |
|
72053 |
BPS Bioscience |
96 rxns. |
EUR 790 |
|
Description: The TPH1 Assay Kit is designed to measure TPH1 enzyme inhibition in a 96 reaction format. This fluorescence-based assay kit is especially suitable for high throughput screening applications. The procedure is quick, straightforward, and simple - just mix two solutions, incubate, add quenching solution, and measure the fluorescence. |
TPH2 Inhibitor Screening Assay Kit |
|
72054 |
BPS Bioscience |
96 rxns. |
EUR 790 |
|
Description: The TPH2 Assay Kit is designed to measure TPH2 enzyme inhibition in a 96 reaction format. This fluorescence-based assay kit is especially suitable for high throughput screening applications. The procedure is quick, straightforward, and simple - just mix two solutions, incubate, add quenching solution, and measure the fluorescence. |
CD73 Inhibitor Screening Assay Kit |
|
72055 |
BPS Bioscience |
96 rxns. |
EUR 935 |
|
Description: The CD73 Inhibitor Screening Assay Kit is designed to measure CD73 activity_x000D_for screening and profiling applications. The CD73 assay kit comes in a convenient 96-well_x000D_format, with purified recombinant CD73 enzyme, AMP, CD73 assay buffer, and Colorimetric_x000D_detection reagent for 100 enzyme reactions. |
TPH1 Inhibitor Screening Assay Kit |
|
72056 |
BPS Bioscience |
384 rxns. |
EUR 1130 |
|
Description: The TPH1 Assay Kit is designed to measure TPH1 enzyme inhibition in a 384 reaction format. This fluorescence-based assay kit is especially suitable for high throughput screening applications. The procedure is quick, straightforward, and simple - just mix two solutions, incubate, add quenching solution, and measure the fluorescence. |
TPH2 Inhibitor Screening Assay Kit |
|
72057 |
BPS Bioscience |
384 rxns. |
EUR 1130 |
|
Description: The TPH2 Assay Kit is designed to measure TPH2 enzyme inhibition in a 384 reaction format. This fluorescence-based assay kit is especially suitable for high throughput screening applications. The procedure is quick, straightforward, and simple - just mix two solutions, incubate, add quenching solution, and measure the fluorescence. |
CD73 Inhibitor Screening Assay Kit |
|
72058 |
BPS Bioscience |
384 rxns. |
EUR 1245 |
|
Description: The CD73 Inhibitor Screening Assay Kit is designed to measure CD73 activity_x000D_for screening and profiling applications. The CD73 assay kit comes in a convenient 384-well_x000D_format, with purified recombinant CD73 enzyme, AMP, CD73 assay buffer, and Colorimetric_x000D_detection reagent for 384 enzyme reactions. |
USP1 Inhibitor Screening Assay Kit |
|
78831 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP1 Inhibitor Screening Assay Kit is a 96-well format fluorogenic assay kit designed to measure the activity of the deubiquitinating (DUB) enzyme USP1 (ubiquitin specific peptidase 1) for screening and profiling applications. The kit contains enough purified USP1/UAF1 (ubiquitin specific peptidase 1 associated factor 1) complex, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP1 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of the DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteasesFigure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases, with a C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with an λexcitation/λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP1? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP5 Inhibitor Screening Assay Kit |
|
78832 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP5 Inhibitor Screening Assay Kit is a 96-well format fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme USP5 for screening and profiling applications. The kit contains enough purified USP5 protein, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP5 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of the DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from the fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with an λexcitation/λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP5? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP2 Inhibitor Screening Assay Kit |
|
78859 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The Ubiquitin specific peptidase 2 (USP2) Inhibitor Screening Assay Kit is a homogeneous fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme USP2 for screening and profiling applications. The kit contains enough purified USP2 recombinant protein, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP2 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with an λexcitation/ λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP2? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP8 Inhibitor Screening Assay Kit |
|
79998 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP8 Inhibitor Screening Assay Kit is a fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme USP8 (ubiquitin specific peptidase 8) for screening and profiling applications. The kit comes in a convenient 96-well format and contains enough purified recombinant human USP8 protein, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP8 activity the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC (Ub-AMC) is a fluorogenic substrate for ubiquitin hydrolases, based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form the energy emitted from the fluorochrome AMC is quenched. Upon release from Ub, AMC emissions are no longer quenched fluorescence with λexcitation/λemission maxima of 350/460 nm is emitted. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP8? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
SIRT6 Inhibitor Screening Kit (Fluorometric) |
|
K323-100 |
Biovision |
each |
EUR 620.4 |
HDAC3 Inhibitor Screening Kit (Fluorometric) |
|
K363-100 |
Biovision |
each |
EUR 738 |
FAAH1 Inhibitor Screening Kit (Fluorometric) |
|
K379-100 |
Biovision |
each |
EUR 705.6 |
HDAC8 Inhibitor Screening Kit (Fluorometric) |
|
K368-100 |
Biovision |
each |
EUR 738 |
HDAC6 Inhibitor Screening Kit (Fluorometric) |
|
K465-100 |
Biovision |
each |
EUR 888 |
Renin Inhibitor Screening Kit (Fluorometric) |
|
K799-100 |
Biovision |
each |
EUR 738 |
BAZ2B Inhibitor Screening Assay Kit |
|
32600 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BAZ2B Inhibitor Screening Assay Kit is designed to measure the inhibition of BAZ2B binding to its substrate. The key to the BAZ2B Inhibitor Screening Assay Kit is the highly specific binding of the BAZ2B bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BAZ2B and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
BRPF3 Inhibitor Screening Assay Kit |
|
32608 |
BPS Bioscience |
384 rxns. |
EUR 1025 |
|
Description: The BRPF3 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRPF3 binding to its substrate. The key to the BRPF3 Inhibitor Screening Assay Kit is the specific binding of the BRPF3 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRPF3 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts |
CECR2 Inhibitor Screening Assay Kit |
|
32611 |
BPS Bioscience |
384 rxns. |
EUR 1025 |
|
Description: The CECR2 Inhibitor Screening Assay Kit is designed to measure the inhibition of CECR2 binding to its substrate. The key to the CECR2 Inhibitor Screening Assay Kit is the highly specific binding of the CECR2 bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing CECR2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
NAMPT Inhibitor Screening Assay Kit |
|
71276-1 |
BPS Bioscience |
96 rxns. |
EUR 560 |
|
Description: The NAMPT Inhibitor Screening Assay Kit is designed to measure NAMPT activity for screening and profiling applications. The NAMPT assay kit comes in a convenient 96-well format, with purified recombinant NAMPT enzyme, NAMPT assay buffer, NAMPT dilution buffer, ATP, Nicotinamide, PRPP, and Ethanol sufficient for 96 enzyme reactions. The key to the assay is a coupled reaction including NMNAT and ADH. NAMPT converts nicotinamide substrate to nicotinamide mononucleotide (NMN) via PRPP. NMNAT subsequently converts NMN to NAD+ , which is reduced by ADH to NADH, permitting detection of the fluorescent NADH signal. |
NAMPT Inhibitor Screening Assay Kit |
|
71276-2 |
BPS Bioscience |
384 rxns. |
EUR 930 |
|
Description: The NAMPT Inhibitor Screening Assay Kit is designed to measure NAMPT activity for screening and profiling applications. The key to the assay is a coupled reaction including NMNAT and ADH. NAMPT converts nicotinamide substrate to nicotinamide mononucleotide (NMN) via PRPP. NMNAT subsequently converts NMN to NAD+ , which is reduced by ADH to NADH, permitting detection of the fluorescent NADH signal. |
MAT2A Inhibitor Screening Assay Kit |
|
71402 |
BPS Bioscience |
384 rxns. |
EUR 1275 |
|
Description: The MAT2a Inhibitor Screening Assay Kit is designed to measure MAT2A activity for screening and profiling applications. The MAT2A assay kit comes in a convenient 384-well format, with purified recombinant MAT2A enzyme, L-Methionine, ATP, MAT2A assay buffer, and Colorimetric detection reagent for 384 enzyme reactions. |
MAT2A Inhibitor Screening Assay Kit |
|
71402-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The MAT2A Inhibitor Screening Assay Kit is designed to measure MAT2A (Methionine Adenosyltransferase 2A) activity for screening and profiling applications. The MAT2A assay kit comes in a convenient format, with purified recombinant MAT2A enzyme, L-Methionine, ATP, MAT2A assay buffer, and colorimetric detection reagent for enzyme reactions.Figure 1: Illustration of the mechanism behind the MAT2A Inhibitor Screening Assay Kit.Need us to run inhibitor screens or profile your MAT2A-directed compound? Check outMetabolic Enzymes Screening and Profiling Services |
MAT2A Inhibitor Screening Assay Kit |
|
71402-2 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The MAT2A Inhibitor Screening Assay Kit is designed to measure MAT2A (Methionine Adenosyltransferase 2A) activity for screening and profiling applications. The MAT2A assay kit comes in a convenient format, with purified recombinant MAT2A enzyme, L-Methionine, ATP, MAT2A assay buffer, and colorimetric detection reagent for enzyme reactions.Figure 1: Illustration of the mechanism behind the MAT2A Inhibitor Screening Assay Kit.Need us to run inhibitor screens or profile your MAT2A-directed compound? Check outMetabolic Enzymes Screening and Profiling Services |
UCHL3 Inhibitor Screening Assay Kit |
|
78815 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The UCHL3 Inhibitor Screening Assay Kit is a 96-well format fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme UCHL3 for screening and profiling applications. To determine the effect of an inhibitor on UCHL3 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with λexcitation/λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against UCHL3? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
UCHL1 Inhibitor Screening Assay Kit |
|
78833 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The UCHL1 Inhibitor Screening Assay Kit is a 96-well format fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme UCHL1 for screening and profiling applications. To determine the effect of an inhibitor on UCHL1 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of the DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU) and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with an λexcitation/λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against UCHL1? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP20 Inhibitor Screening Assay Kit |
|
78840 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP20 Inhibitor Screening Assay Kit is a 96-well format fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme USP20 for screening and profiling applications. To determine the effect of an inhibitor on USP20 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with λexcitation/ λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP20? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP14 Inhibitor Screening Assay Kit |
|
78865 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP14 Inhibitor Screening Assay Kit is a 96-well fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme USP14 (Ubiquitin specific peptidase 14) for screening and profiling applications. The kit contains enough purified USP14 protein, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP14 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In conjugated form, the energy emitted from the fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with λexcitation/λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP14? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP10 Inhibitor Screening Assay Kit |
|
79094 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP10 Inhibitor Screening Assay Kit is a fluorogenic assay designed to measure the activity of the deubiquitinating (DUB) enzyme USP10 (Ubiquitin Specific Peptidase 10) for screening and profiling applications. The kit comes in a convenient 96-well format and contains enough purified recombinant human USP10 protein, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP10 activity the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU) and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC (Ub-AMC) is a fluorogenic substrate for ubiquitin hydrolases, based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form the energy emitted from the fluorochrome AMC is quenched. Upon release from Ub, AMC emissions are no longer quenched and fluorescence with λexcitation/λemission maxima of 350/460 nm is emitted. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP10? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP9X Inhibitor Screening Assay Kit |
|
82726-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP9X Inhibitor Screening Assay Kit is a fluorogenic assay kit designed to measure the activity of the deubiquitinating (DUB) enzyme USP9X (ubiquitin specific peptidase 9 X-linked) for screenin82726-1g and profiling applications. The kit contains enough purified USP9X, Ubiquitinated-AMC substrate, and assay buffer for 96 reactions.To determine the effect of an inhibitor on USP9X activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of the DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC is a fluorogenic substrate for ubiquitin hydrolases, with a C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form, the energy emitted from fluorochrome AMC is quenched. Upon proteolysis, AMC is no longer quenched and emits fluorescence with an λexcitation/λemission maxima of 350/460 nm. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP14? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
USP22 Inhibitor Screening Assay Kit |
|
82742 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The USP22 Inhibitor Screening Assay Kit is a fluorogenic assay kit designed to measure the activity of the deubiquitinating (DUB) enzyme USP22 (ubiquitin specific peptidase 22) for screening and profiling applications. The kit contains enough purified USP22, Ubiquitinated-AMC substrate, and assay buffer for 100 reactions.To determine the effect of an inhibitor on USP22 activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the Ub-AMC substrate to the reaction. The assay was functionally validated using Ub-Aldehyde, a potent inhibitor of the DUB subfamilies Ubiquitin C-terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), Ovarian Tumor Proteases (OTU), and Machado-Josephin Domain (MJD) proteases.Figure 1: Illustration of the assay principle.Ubiquitin-AMC (Ub-AMC) is a fluorogenic substrate for ubiquitin hydrolases, based on the C-terminus derivatization of ubiquitin with 7-amido-4-methylcoumarin (AMC) . In the conjugated form the energy emitted from the fluorochrome AMC is quenched. Upon release from Ub, AMC emissions are no longer quenched fluorescence with λexcitation/λemission maxima of 350/460 nm is emitted. The increase in fluorescence is proportional to the DUB activity.Need us to run inhibitor screens or profile your compounds against USP22? Check out ourProtease Screening ServicesorUbiquitination Screening Services. |
Neutrophil Elastase Inhibitor Screening Kit |
|
GWB-AXR357 |
GenWay Biotech |
100 assays |
Ask for price |
SARS-CoV-2 Inhibitor Screening ELISA Kit |
|
DEIA-WZ021 |
Creative Diagnostics |
96T |
EUR 1071 |
|
Description: Serum, Plasma |
ATAD2A Inhibitor Screening Assay Kit |
|
32601 |
BPS Bioscience |
384 rxns. |
EUR 1025 |
|
Description: The ATAD2A Inhibitor Screening Assay Kit is designed to measure the inhibition of ATAD2A binding to its substrate. The key to the ATAD2A Inhibitor Screening Assay Kit is a specific binding of the ATAD2A bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing ATAD2A and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
ATAD2B Inhibitor Screening Assay Kit |
|
32605 |
BPS Bioscience |
384 rxns. |
EUR 1025 |
|
Description: The ATAD2B Inhibitor Screening Assay Kit is designed to measure the inhibition of ATAD2B binding to its substrate. The key to the kit is the specific binding of the ATAD2B bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing ATAD2B and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
TRIM24 Inhibitor Screening Assay Kit |
|
32606 |
BPS Bioscience |
384 rxns. |
EUR 1025 |
|
Description: The TRIM24 Inhibitor Screening Assay Kit is designed to measure the inhibition of TRIM24 binding to its substrate. The key to the TRIM24 Inhibitor Screening Assay Kit is the specific binding of the TRIM24 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing TRIM24 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
CREBBP Inhibitor Screening Assay Kit |
|
32607 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The CREBBP Inhibitor Screening Assay Kit is designed to measure the inhibition of CREBBP binding to its substrate. The key to the CREBBP Inhibitor Screening Assay Kit is a specific binding of the CREBBP bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing CREBBP and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
Plasmin Inhibitor Screening Kit (Fluorometric) |
|
K382-100 |
Biovision |
each |
EUR 666 |
QuantiChrom Arginase Inhibitor Screening Kit |
|
IARG-100 |
BioAssay Systems |
100 |
EUR 279 |
SMARCA2 Inhibitor Screening Assay Kit |
|
32610 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The SMARCA2 Inhibitor Screening Assay Kit is designed to measure the inhibition of SMARCA2 binding to its substrate. The key to the SMARCA2 Inhibitor Screening Assay Kit is the specific binding of the SMARCA2 bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing SMARCA2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
Thrombin Inhibitor Screening Kit (Fluorometric) |
|
K374-100 |
Biovision |
each |
EUR 914.4 |
Thrombin Inhibitor Screening Assay Kit |
|
78867-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The Thrombin Inhibitor Screening Assay is a colorimetric assay designed to measure the activity of human alpha thrombin for screening and profiling applications. The assay kit comes in a convenient 96-well or 384-well format and contains enough purified human alpha thrombin, a chromogenic substrate, and PR-02 buffer for 100 or 400 reactions.To determine the effect of an inhibitor on Thrombin activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the chromogenic substrate to the reaction. The assay was functionally validated using Dabigatran, a potent inhibitor of thrombin.Figure 1: Illustration of the assay principle.Upon proteolysis, thrombin cleaves the chromogenic substrate at the C-terminal end releasing p-nitroanilid (pNA), which produces a yellow color that is measurable photometrically at λ=405 nm. The increase in color is proportional to thrombin activity. |
Thrombin Inhibitor Screening Assay Kit |
|
78867-2 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The Thrombin Inhibitor Screening Assay is a colorimetric assay designed to measure the activity of human alpha thrombin for screening and profiling applications. The assay kit comes in a convenient 96-well or 384-well format and contains enough purified human alpha thrombin, a chromogenic substrate, and PR-02 buffer for 100 or 400 reactions.To determine the effect of an inhibitor on Thrombin activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the chromogenic substrate to the reaction. The assay was functionally validated using Dabigatran, a potent inhibitor of thrombin.Figure 1: Illustration of the assay principle.Upon proteolysis, thrombin cleaves the chromogenic substrate at the C-terminal end releasing p-nitroanilid (pNA), which produces a yellow color that is measurable photometrically at λ=405 nm. The increase in color is proportional to thrombin activity. |
Diablo:XIAP Inhibitor Screening Assay Kit |
|
82516 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The Diablo:XIAP Inhibitor Screening Assay Kit is an ELISA-based assay designed to measure the binding between Diablo (also named Smac) and E3 ubiquitin-protein ligase XIAP (X-linked inhibitor of apoptosis, also known as mammalian IAP homolog A) for screening and profiling applications. The Diablo:XIAP Inhibitor Screening Assay Kit comes with enough purified Diablo (amino acids 56-239) and XIAP proteins, primary and secondary antibody, assay buffer, and detection reagent for 100 enzyme reactions.Figure 1. Diablo:XIAP Binding Chemiluminescent Assay Kit schematic.A 96-well plate is coated with purified Diablo protein. After coating and blocking, XIAP is added in an optimized assay buffer. Next, unbound XIAP is washed away and the plate is incubated with a primary antibody, followed by a secondary HRP-conjugated antibody. Finally, ELISA ECL substrate is added to produce chemiluminescence that can be measured using a chemiluminescence reader. The chemiluminescence signal is proportional to the binding of XIAP to Diablo.Need us to run inhibitor screens or profile your compounds against Diablo:XIAP binding? Check out ourUbiquitination Screening and Profiling Service. |
Urokinase Inhibitor Screening Kit (Fluorometric) |
|
K727-100 |
Biovision |
each |
EUR 627.6 |
Neprilysin Inhibitor Screening Kit (Fluorometric) |
|
K996-100 |
Biovision |
each |
EUR 744 |
Tyrosinase Inhibitor Screening Kit (Colorimetric) |
|
K575-100 |
Biovision |
each |
EUR 966 |
MMP-3 Inhibitor Screening Kit (Fluorometric) |
|
K793-100 |
Biovision |
each |
EUR 724.8 |
MMP-1 Inhibitor Screening Kit (Fluorometric) |
|
K794-100 |
Biovision |
each |
EUR 738 |
MMP-9 Inhibitor Screening Kit (Fluorometric) |
|
K844-100 |
Biovision |
each |
EUR 732 |
CETP Inhibitor Screening Kit (Fluorometric) II |
|
K594-100 |
Biovision |
each |
EUR 810 |
SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD) |
|
EP-107 |
ACROBIOSYSTEMS |
96tests |
EUR 664.9 |
|
|
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. The deleloped of effcient treatment agaginst SARS-CoV-2 is an emergent need for global pubic heath,and it is necessary to develop SARS-CoV-2 inhibitors, such as vaccines, therapeutic antibodies and small molecule compounds against SARS-CoV-2. Therefore, it is helpful to develop the SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors. |
?-Glucosidase Inhibitor Screening Kit (Colorimetric) |
|
K938-100 |
Biovision |
each |
EUR 705.6 |
Collagenase Inhibitor Screening Kit (Fluorometric) |
|
K833-100 |
Biovision |
each |
EUR 496.8 |
Caspase-1 Inhibitor Drug Screening Kit |
|
GWB-AXR115 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-3 Inhibitor Drug Screening Kit |
|
GWB-AXR117 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-4 Inhibitor Drug Screening Kit |
|
GWB-AXR118 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-5 Inhibitor Drug Screening Kit |
|
GWB-AXR119 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-6 Inhibitor Drug Screening Kit |
|
GWB-AXR120 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-7 Inhibitor Drug Screening Kit |
|
GWB-AXR121 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-8 Inhibitor Drug Screening Kit |
|
GWB-AXR122 |
GenWay Biotech |
100 assays |
Ask for price |
Caspase-9 Inhibitor Drug Screening Kit |
|
GWB-AXR123 |
GenWay Biotech |
100 assays |
Ask for price |
HDAC-5 Inhibitor Screening Kit (Fluorometric) |
|
K171-100 |
Biovision |
each |
EUR 732 |
MMP-14 Inhibitor Screening Kit (Fluorometric) |
|
K846-100 |
Biovision |
each |
EUR 802.8 |
BRD3 (BD1) Inhibitor Screening Assay Kit |
|
32513 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD3 (BD1) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD3 bromodomain 1 (BD1) from binding to its substrate. The key to the BRD3 (BD1) Inhibitor Screening Assay Kit is the highly specific binding of the BRD3 bromodomain 1 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD3 bromodomain 1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
BRD4 (BD1) Inhibitor Screening Assay Kit |
|
32514 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD4 (BD1) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD4 bromodomain 1 (BD1) from binding to its substrate. The key to the BRD4 (BD1) Inhibitor Screening Assay Kit is the highly specific binding of the BRD4 bromodomain 1 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD4 bromodomain 1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
BRD9 (BD1) Inhibitor Screening Assay Kit |
|
32519 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD9 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD9 binding to its substrate. The key to the BRD9 Inhibitor Screening Assay Kit is the specific binding of the BRD9 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD9 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
BRD2 (BD2) Inhibitor Screening Assay Kit |
|
32522 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD2 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD2 bromodomain 2 (BD2) from binding to its substrate. The key to the BRD2 (BD2) Inhibitor Screening Assay Kit is the highly specific binding of the BRD2 bromodomain 2 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD2 bromodomain 2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
BRD3 (BD2) Inhibitor Screening Assay Kit |
|
32523 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD3 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD3 bromodomain 2 (BD2) from binding to its substrate. The key to the BRD3 (BD2) Inhibitor Screening Assay Kit is the highly specific binding of the BRD3 bromodomain 2 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD3 bromodomain 2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
BRD4 (BD2) Inhibitor Screening Assay Kit |
|
32524 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRD4 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD4 bromodomain 2 (BD2) binding to its substrate. The key to the BRD4 (BD2) Inhibitor Screening Assay Kit is the highly specific binding of the BRD4 bromodomain 2 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD4 bromodomain 2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
DR3:TL1A Inhibitor Screening Assay Kit |
|
82241-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The DR3:TL1A Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of the interaction between DR3 (Death Receptor 3) and TL1A (TNF-like ligand 1A) . This kit comes in a convenient 96-well or 384-well format, with biotin-labeled TL1A (amino acids 72-end), purified DR3 (amino acids 25-199), streptavidin-labeled HRP, and assay buffer for 100 or 400 binding reactions.Figure 1:DR3:TL1A Inhibitor Screening Assay Kit workflow diagram.First, DR3 is coated on a 96-well or 384-well plate. Next, biotinylated TL1A is incubated with DR3. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence. The chemiluminescence signal is proportional to the binding of DR3:TL1ANeed us to run inhibitor screens or profile your compounds against DR3:TL1A? Check out ourImmunotherapy Biochemical Screening Services. |
DR3:TL1A Inhibitor Screening Assay Kit |
|
82241-2 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The DR3:TL1A Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of the interaction between DR3 (Death Receptor 3) and TL1A (TNF-like ligand 1A) . This kit comes in a convenient 96-well or 384-well format, with biotin-labeled TL1A (amino acids 72-end), purified DR3 (amino acids 25-199), streptavidin-labeled HRP, and assay buffer for 100 or 400 binding reactions.Figure 1:DR3:TL1A Inhibitor Screening Assay Kit workflow diagram.First, DR3 is coated on a 96-well or 384-well plate. Next, biotinylated TL1A is incubated with DR3. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence. The chemiluminescence signal is proportional to the binding of DR3:TL1ANeed us to run inhibitor screens or profile your compounds against DR3:TL1A? Check out ourImmunotherapy Biochemical Screening Services. |
Caspase-10 Inhibitor Drug Screening Kit |
|
GWB-AXR124 |
GenWay Biotech |
100 assays |
Ask for price |
Factor Xa Inhibitor Screening Kit (Fluorometric) |
|
K362-100 |
Biovision |
each |
EUR 764.4 |
Rat Renin Inhibitor Screening Kit (Fluorometric) |
|
K798-100 |
Biovision |
each |
EUR 874.8 |
15-PGDH Inhibitor Screening Kit (Fluorometric) |
|
K503-100 |
Biovision |
each |
EUR 874.8 |
QuantiFluo α-Amylase Inhibitor Screening Kit |
|
IAMY-400 |
BioAssay Systems |
400 |
EUR 439 |
TAF1L (BD2) Inhibitor Screening Assay Kit |
|
32602 |
BPS Bioscience |
384 rxns. |
EUR 1025 |
|
Description: The TAF1L (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of TAF1L binding to its substrate. The key to the assay kit is specific binding of the TAF1L bromodomain 2 (a.a. 1517-1649) to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing TAF1L and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
Human TDO Inhibitor Screening Assay Kit |
|
72023 |
BPS Bioscience |
96 rxns. |
EUR 745 |
|
Description: The TDO Inhibitor Screening Assay Kit is designed to measure TDO enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 100 reactions. The TDO Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing L-Trp substrate. After a room temperature incubation activity is measured by measuring the absorption of reaction product at λ = 320-325 nm. |
FGL1:LAG3 Inhibitor Screening Assay Kit |
|
78824 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The FGL1:LAG3 Inhibitor Screening Assay is an AlphaLISA®-based assay designed to measure the inhibition of LAG3 binding to FGL1 in a homogeneous 384-reaction format. The assay is straightforward: first, FGL1 and LAG3 are incubated with or without a compound of interest. Then, acceptor and donor beads are added to the reaction, followed by reading the Alpha-counts.Illustration of the assay principle.FGL1 contains a His tag recognized by the Nickel chelate acceptor bead, whereas LAG3 is biotinylated, allowing its binding to the streptavidin-coated acceptor bead. Interaction between FGL1 and its receptor LAG3 brings the donor and acceptor beads in proximity. A singlet oxygen generated upon excitation of the donor bead leads to the excitation of the acceptor bead, which emits light. Light emission in the assay is proportional to the level of interaction. AlphaLISA™ immunoassays are a no-wash alternative to ELISA. These assays are robust, highly amenable to high throughput applications, and ideal for a minimal hands-on approach.Need us to run inhibitor screens or profile your compounds against FGL1:LAG3? Check out ourImmunotherapy Biochemical Screening Services. |
Factor Xa Inhibitor Screening Assay Kit |
|
78868-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The Factor Xa Inhibitor Screening Assay is a colorimetric assay designed to measure the activity of human Factor Xa for screening and profiling applications. The assay kit comes in a convenient 96-well format or 384-well format and contains enough purified human Factor Xa, a chromogenic substrate, and PR-02 buffer for 100 or 400 reactions.To determine the effect of an inhibitor on Factor Xa activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the chromogenic substrate to the reaction. The assay was functionally validated using Rivaroxaban, a potent inhibitor of Factor Xa.Figure 1: Illustration of the assay principle.Upon proteolysis, Factor Xa cleaves the chromogenic substrate at the C-terminal end releasing p-nitroanilid (pNA), which produces a yellow color that is measurable photometrically at λ=405 nm. The increase in color is proportional to Factor Xa activity. |
Factor Xa Inhibitor Screening Assay Kit |
|
78868-2 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The Factor Xa Inhibitor Screening Assay is a colorimetric assay designed to measure the activity of human Factor Xa for screening and profiling applications. The assay kit comes in a convenient 96-well format or 384-well format and contains enough purified human Factor Xa, a chromogenic substrate, and PR-02 buffer for 100 or 400 reactions.To determine the effect of an inhibitor on Factor Xa activity, the enzyme should be preincubated with or without the test inhibitor prior to adding the chromogenic substrate to the reaction. The assay was functionally validated using Rivaroxaban, a potent inhibitor of Factor Xa.Figure 1: Illustration of the assay principle.Upon proteolysis, Factor Xa cleaves the chromogenic substrate at the C-terminal end releasing p-nitroanilid (pNA), which produces a yellow color that is measurable photometrically at λ=405 nm. The increase in color is proportional to Factor Xa activity. |
Caspase-2 Inhibitor Drug Screening Kit (Fluorometric) |
|
K152-100 |
Biovision |
each |
EUR 666 |
Caspase-2 Inhibitor Drug Screening Kit (Fluorometric) |
|
K2158-100 |
ApexBio |
100 assays |
EUR 812.8 |
|
Description: Kits|Apoptosis Kit#Apoptosis Kit|Caspase Inhibitor Screening Kit#Kits |
Kynureninase Inhibitor Screening Assay Kit |
|
79514 |
BPS Bioscience |
100 rxns. |
EUR 830 |
|
Description: The Kynureninase (KYNU) Inhibitor Screening Assay Kit is designed to measure human KYNU enzyme inhibition. The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 100 reactions. The KYNU Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are mixed and the reaction is initiated through addition of the substrate 3-hydroxy-DL-kynurenine (3-HK). After a room temperature incubation, activity is determined by measuring the fluorescence of the reaction product (ex. 315 nm, em. 415 nm). |
UCH-L1 Deubiquitinase Inhibitor Screening Kit |
|
K484-100 |
Biovision |
each |
EUR 901.2 |
UCH-L3 Deubiquitinase Inhibitor Screening Kit |
|
K471-100 |
Biovision |
each |
EUR 744 |
Human IDO1 Inhibitor Screening Assay Kit |
|
72021 |
BPS Bioscience |
96 rxns. |
EUR 780 |
|
Description: The IDO1 Inhibitor Screening Assay Kit is designed to measure IDO1 enzyme inhibition. The IDO1 Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing L-Trp substrate. After a room temperature incubation, activity is determined by measuring the absorption of reaction product at λ=321 nm. |
Human IDO2 Inhibitor Screening Assay Kit |
|
72022 |
BPS Bioscience |
96 rxns. |
EUR 900 |
|
Description: The IDO2 Inhibitor Screening Assay Kit is designed to measure IDO2 enzyme inhibition. The IDO2 Inhibitor Screening Assay Kit is simple to use. Inhibitor and enzyme are added to a sample containing L-Trp substrate. |
Mouse IDO1 Inhibitor Screening Assay Kit |
|
72041 |
BPS Bioscience |
96 rxns. |
EUR 745 |
|
Description: The Mouse IDO1 Inhibitor Screening Assay Kit is designed to measure inhibition of the murine IDO1 enzyme. This kit is simple to use. Inhibitor and enzyme are added to a sample containing L-Trp substrate. After a room temperature incubation, activity is determined by measuring the absorption of reaction product at l=320-325 nm. |
Mouse IDO2 Inhibitor Screening Assay Kit |
|
72042 |
BPS Bioscience |
96 rxns. |
EUR 860 |
|
Description: The IDO2 Inhibitor Screening Assay Kit is designed to measure mouse IDO2_x000D_enzyme inhibition. The Mouse IDO2 Inhibitor Screening Assay Kit is_x000D_simple to use. Inhibitor and enzyme are added to a sample containing L-Trp substrate. After a_x000D_room temperature incubation, activity is determined by measuring the absorption of reaction_x000D_product at l=320 - 325 nm._x000D_BACKGROUND: L-tryptophan |
SARS-CoV-2 (B.1.351) Inhibitor Screening Kit (Spike RBD) |
|
EP-109 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
|
|
Description: Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, the deleloped of effcient treatment agaginst multiple variants of SARS-CoV-2 is an emergent need for global pubic heath.It is necessary to develop SARS-CoV-2 inhibitors, such as vaccines,therapeutic antibodies and small molecule compounds against SARS-CoV-2(B.1.351).Therefore, it is helpful to develop the SARS-CoV-2 (B.1.351) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors. |
SARS-CoV-2 (B.1.617.2) Inhibitor Screening Kit (Spike RBD) |
|
EP-111 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
|
|
Description: Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, the deleloped of effcient treatment agaginst multiple variants of SARS-CoV-2 is an emergent need for global pubic heath.It is necessary to develop SARS-CoV-2 inhibitors, such as vaccines,therapeutic antibodies and small molecule compounds against SARS-CoV-2(B.1.617.2). Therefore, it is helpful to develop the SARS-CoV-2 (B.1.617.2) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors. |
SARS-CoV-2 (B.1.1.529) Inhibitor Screening Kit (Spike RBD) |
|
EP-115 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
|
|
Description: As of Nov 29th, confirmed cases of a new variant of concern (VOC) B.1.1.529 have been reported in South Africa, Botswana and more than 12 other countries. Thanks to the rapid sequencing efforts of South African scientists, the whole world is now alerted about this potentially devastating lineage, which was assigned the name Omicron by WHO.Omicron is a highly divergent variant with a high number of mutations (26-35) in the spike. Identification of some familiar mutations that also appeared on other VOCs gives rises to concerns of its immune escape potential and higher transmissibility,it is necessary to develop SARS-CoV-2 inhibitors, such as vaccines,therapeutic antibodies and small molecule compounds against SARS-CoV-2(B.1.1.529). The SARS-CoV-2 (B.1.1.529) Inhibitor Screening Kit (Spike RBD) is helpful to develop the to test SARS-CoV-2 inhibitors. |
Granzyme B Inhibitor Screening Kit (Fluorometric) |
|
K169-100 |
Biovision |
each |
EUR 836.4 |
EnzyFluo Farnesyltransferase Inhibitor Screening Kit |
|
EIFT-400 |
BioAssay Systems |
400 |
EUR 369 |
SARS-CoV-2 (B.1.1.7) Inhibitor Screening Kit (Spike RBD) |
|
EP-108 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
|
|
Description: Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, the deleloped of effcient treatment agaginst multiple variants of SARS-CoV-2 is an emergent need for global pubic heath.It is necessary to develop SARS-CoV-2 inhibitors, such as vaccines,therapeutic antibodies and small molecule compounds against SARS-CoV-2(B.1.1.7). Therefore, it is helpful to develop the SARS-CoV-2 (B.1.1.7) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors. |
SARS-CoV-2 (P.1) Inhibitor Screening Kit (Spike RBD) |
|
EP-110 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
|
|
Description: Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, the deleloped of effcient treatment agaginst multiple variants of SARS-CoV-2 is an emergent need for global pubic heath.It is necessary to develop SARS-CoV-2 inhibitors, such as vaccines,therapeutic antibodies and small molecule compounds against SARS-CoV-2(P.1).Therefore, it is helpful to develop the SARS-CoV-2 (P.1) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors. |
Cathepsin E Inhibitor Screening Kit (Fluorometric) |
|
K166-100 |
Biovision |
each |
EUR 1123.2 |
Cathepsin H Inhibitor Screening Kit (Fluorometric) |
|
K164-100 |
Biovision |
each |
EUR 901.2 |
Cathepsin L Inhibitor Screening Kit (Fluorometric) |
|
K161-100 |
Biovision |
each |
EUR 777.6 |
Cathepsin G Inhibitor Screening Kit (Colorimetric) |
|
K162-100 |
Biovision |
each |
EUR 770.4 |
Cathepsin D Inhibitor Screening Kit (Fluorometric) |
|
K148-100 |
Biovision |
each |
EUR 751.2 |
Cathepsin S Inhibitor Screening Kit (Fluorometric) |
|
K149-100 |
Biovision |
each |
EUR 751.2 |
Cathepsin K Inhibitor Screening Kit (Fluorometric) |
|
K150-100 |
Biovision |
each |
EUR 777.6 |
Cathepsin D Inhibitor Screening Kit (Fluorometric) |
|
K2156-100 |
ApexBio |
100 assays |
EUR 1024 |
|
Description: Proteases/Proteasome Kit|Cathepsin Kit#Kits|Proteases/Proteasome Kit#Kits |
TEV Protease Inhibitor Screening Kit (Fluorometric) |
|
K843-100 |
Biovision |
each |
EUR 483.6 |
Hexokinase (HK) Inhibitor Screening Kit (Colorimetric) |
|
K828-100 |
Biovision |
each |
EUR 764.4 |
Human Enolase ? Inhibitor Screening Kit (Colorimetric) |
|
K526-100 |
Biovision |
each |
EUR 744 |
SMARCA4/BRG1 Inhibitor Screening Assay Kit |
|
32609 |
BPS Bioscience |
384 rxns. |
EUR 510 |
|
Description: The BRG1 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRG1 binding to its substrate. The key to the BRG1 Inhibitor Screening Assay Kit is the specific binding of the BRG1 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRG1 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts. |
Cathepsin S Inhibitor Screening Assay Kit |
|
79588 |
BPS Bioscience |
96 rxns. |
EUR 515 |
|
Description: The Cathepsin S Inhibitor Screening Assay Kit is designed to measure the protease activity of Cathepsin S for screening and profiling applications. The Cathepsin S assay kit comes in a convenient 96-well format, with purified Cathepsin S, its fluorogenic substrate, and Cathepsin buffer for 100 enzyme reactions. In addition, the kit includes the cathepsin inhibitor E64 for use as a control inhibitor. |
Cathepsin V Inhibitor Screening Assay Kit |
|
79589 |
BPS Bioscience |
96 rxns. |
EUR 515 |
|
Description: The Cathepsin V Inhibitor Screening Assay Kit is designed to measure the protease activity of Cathepsin V for screening and profiling applications. The Cathepsin V assay kit comes in a convenient 96-well format, with purified Cathepsin V, its fluorogenic substrate, and Cathepsin buffer for 100 enzyme reactions. In addition, the kit includes the cathepsin inhibitor E64 for use as a control inhibitor. |
Cathepsin B Inhibitor Screening Assay Kit |
|
79590 |
BPS Bioscience |
96 rxns. |
EUR 515 |
|
Description: The Cathepsin B Inhibitor Screening Assay Kit is designed to measure the protease activity of Cathepsin B for screening and profiling applications. The Cathepsin B assay kit comes in a convenient 96-well format, with purified Cathepsin B, its fluorogenic substrate, and Cathepsin buffer for 100 enzyme reactions. In addition, the kit includes the cathepsin inhibitor E64 for use as a control inhibitor. |
Cathepsin L Inhibitor Screening Assay Kit |
|
79591 |
BPS Bioscience |
96 rxns. |
EUR 540 |
|
Description: The Cathepsin L Inhibitor Screening Assay Kit is designed to measure the protease activity of Cathepsin L for screening and profiling applications. The Cathepsin L assay kit comes in a convenient 96-well format, with purified Cathepsin L, its fluorogenic substrate, and Cathepsin buffer for 100 enzyme reactions. In addition, the kit includes the cathepsin inhibitor E64 for use as a control inhibitor. |
KEAP1-Nrf2 Inhibitor Screening Assay Kit |
|
72020 |
BPS Bioscience |
96 rxns. |
EUR 960 |
|
Description: The Keap1:Nrf2 Inhibitor Screening Assay Kit is designed for_x000D_identification of inhibitors of Keap1:Nrf2 binding using fluorescence polarization. Using this kit, only one simple step on a microtiter plate is required for_x000D_Keap1:Nrf2 inhibitor screening reactions. The Keap1 protein and fluorescently labeled_x000D_Nrf2 peptide are incubated with a sample containing testing inhibitors for 30 minutes._x000D_The change in fluorescent polarization can then be measured using a fluorescence_x000D_reader. |
TNFSF11 : RANK Inhibitor Screening ELISA Kit |
|
EP-144 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
|
|
Description: Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL, through its ability to stimulate osteoclast formation and activity, is a critical mediator of bone resorption and overall bone density. Some findings also suggestion some cancer cells, particularly prostate cancer cells, can activate an increase in bone remodeling and ultimately increase overall bone production.[17] This increase in bone remodeling and bone production increases the overall growth of bone metastasizes. The overall control of bone remodeling is regulated by the binding of RANKL with its receptor or its decoy receptor, respectively, RANK and OPG. |
TNFSF11 : RANK Inhibitor Screening ELISA Kit |
|
EP-144-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL, through its ability to stimulate osteoclast formation and activity, is a critical mediator of bone resorption and overall bone density. Some findings also suggestion some cancer cells, particularly prostate cancer cells, can activate an increase in bone remodeling and ultimately increase overall bone production.[17] This increase in bone remodeling and bone production increases the overall growth of bone metastasizes. The overall control of bone remodeling is regulated by the binding of RANKL with its receptor or its decoy receptor, respectively, RANK and OPG. |
Cathepsin K Inhibitor Screening Assay Kit |
|
78810-1 |
BPS Bioscience |
96 Reactions |
Ask for price |
|
|
|
Description: The Cathepsin K Inhibitor Screening Assay Kit is designed to measure the protease activity of Cathepsin K for screening and profiling applications. The Cathepsin K assay kit comes in a convenient 96-well or 384-well format, with enough purified Cathepsin K, its substrate, and Cathepsin Buffer for 96 or 384 reactions. This kit includes the inhibitor E-64 as control.Figure 1: Illustration of the assay principle.The substrate is an internally quenched flourogenic substrate.Proteolysis releases the highly flourescent Mca from the quencher. Flourescence intensity increases proportionally to the activity og the protease.Need us to run inhibitor screens or profile your compounds against Cathepsin K? Check out ourProtease Screening Services. |
Cathepsin K Inhibitor Screening Assay Kit |
|
78810-2 |
BPS Bioscience |
384 Reactions |
Ask for price |
|
|
|
Description: The Cathepsin K Inhibitor Screening Assay Kit is designed to measure the protease activity of Cathepsin K for screening and profiling applications. The Cathepsin K assay kit comes in a convenient 96-well or 384-well format, with enough purified Cathepsin K, its substrate, and Cathepsin Buffer for 96 or 384 reactions. This kit includes the inhibitor E-64 as control.Figure 1: Illustration of the assay principle.The substrate is an internally quenched flourogenic substrate.Proteolysis releases the highly flourescent Mca from the quencher. Flourescence intensity increases proportionally to the activity og the protease.Need us to run inhibitor screens or profile your compounds against Cathepsin K? Check out ourProtease Screening Services. |
COX-2 Inhibitor Screening Kit